Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ADP-A2M4CD8 |
Synonyms | |
Therapy Description |
ADP-A2M4CD8 comprises autologous T-cells engineered to express a CD8alpha co-receptor and a T-cell receptor (TCR) targeting MAGE-A4, which potentially induces antitumor activity (J Clin Oncol 41, 2023 (suppl 6; abstr 517)). |